The 36th ENA Molecular Targets and Cancer Therapeutics Symposium
The 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics will be held in person at the CCIB in Barcelona in October 2024.
ENA 2024 is a premier event focused on drug development and translational research, emphasizing preclinical and phase I studies and facilitating comprehensive scientific discussions on the latest advances in targets and therapeutics.
This symposium draws a global audience of academics, scientists, and pharmaceutical industry leaders, providing a platform for detailed discussions on cutting-edge innovations in drug development, target selection, and the impact of new molecular biology discoveries.
EORTC – European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:
“Join us at the 36th EORTC-NCI-AACR (ENA) Molecular Targets and Cancer Therapeutics Symposium on 23-25 October 2024 in Barcelona!
This prestigious meeting unites laboratory specialists, translational research experts, drug developers, physicians, and methodologists to promote collaboration and understanding between the various disciplines relevant to drug development, translational research, and molecular target validation.
Come and be part of this community and benefit from the many insights and networking opportunities it offers.
Register now.”
Proceed to the video attached to the post.
Source: EORTC /LinkedIn